🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a phase 2b, randomized, multicenter, parallel group, partially blin...
Status
Terminated
Location
GSK Investigational Site
Start Date
2020-11-18
Trial ID
NCT04493216
Treatments Being Tested
This is an open-label, 2 part, single-dose and crossover study conducted to...
Status
Completed
Location
GSK Investigational Site
Start Date
2020-01-27
Trial ID
NCT04263142
Treatments Being Tested
Human immunodeficiency virus (HIV) infection frequently involves combinatio...
Status
Completed
Location
GSK Investigational Site
Start Date
2019-02-11
Trial ID
NCT03836729
Treatments Being Tested
This is an open-label, single-sequence, multiple-dose, 3 cohort study to in...
Status
Completed
Location
GSK Investigational Site
Start Date
2020-10-28
Trial ID
NCT04630002
Treatments Being Tested
This is an open-label, single-sequence, two-way drug interaction study to i...
Status
Completed
Location
GSK Investigational Site
Start Date
2019-01-23
Trial ID
NCT03816696
Treatments Being Tested
This is an open-label, single-sequence, 1-way drug-drug interaction study t...
Status
Completed
Location
GSK Investigational Site
Start Date
2019-06-13
Trial ID
NCT03984825
Treatments Being Tested
This is an open-label, single sequence study that is being conducted to inv...
Status
Completed
Location
GSK Investigational Site
Start Date
2020-12-16
Trial ID
NCT04425902
This is an open-label, single-center, single group, non-randomized, two-per...
Status
Completed
Location
GSK Investigational Site
Start Date
2020-09-24
Trial ID
NCT04507321
Treatments Being Tested
This is a two part study to compare the relative bioavailability (BA) of 2 ...
Status
Completed
Location
GSK Investigational Site
Start Date
2021-04-21
Trial ID
NCT04857892
Treatments Being Tested
This is an open-label, single-dose, four-period, four sequential, and cross...
Status
Terminated
Location
GSK Investigational Site
Start Date
2019-10-08
Trial ID
NCT04128293
Treatments Being Tested